Ayres J G, Crocker J G, Skilbeck N Q
Department of Respiratory Medicine, East Birmingham Hospital.
Thorax. 1988 May;43(5):366-70. doi: 10.1136/thx.43.5.366.
Nucleolar organiser regions represent nucleolar activity in both normal and malignant cells. More numerous nucleolar organiser regions have been found in cells from many forms of malignancy than in normal cells. An argyrophilic method of staining these regions (the AgNOR technique) has been applied to specimens of pleura obtained by biopsy or at necropsy in an attempt to differentiate between normal, "reactive," and malignant pleural disease. The number of nucleolar organiser regions in samples taken from 10 patients with normal pleura (mean 1.04 (95% confidence interval 0.96-1.12] was less than the number seen in samples from 10 patients with "reactive" (inflammatory) pleural disease (1.75 (1.34-2.16); p less than 0.001). This is the first demonstration of increased numbers of nucleolar organiser regions in an inflammatory condition. In specimens from 25 patients with mesothelioma the corresponding numbers of nucleolar organiser regions were: tubulopapillary (n = 10) 5.43 (4.42-6.44); undifferentiated (n = 5) 5.00 (3.29-6.71); sarcomatous (n = 5) 7.52 (3.96-11.08); and mixed histological types (n = 5) 4.94 (3.2-6.68). All these values differ significantly from those for both normal and "reactive" tissue (p less than 0.001). It is concluded that the AgNOR technique separates "reactive" pleural disease from mesothelioma with a high degree of confidence and is an important advance in the diagnosis of malignant mesothelioma.
核仁组织区代表正常细胞和恶性细胞中的核仁活性。在多种恶性肿瘤的细胞中发现的核仁组织区比正常细胞中更多。一种对这些区域进行嗜银染色的方法(AgNOR技术)已应用于通过活检或尸检获得的胸膜标本,以试图区分正常、“反应性”和恶性胸膜疾病。从10例正常胸膜患者的样本中获得的核仁组织区数量(平均值为1.04(95%置信区间0.96 - 1.12))少于从10例“反应性”(炎症性)胸膜疾病患者的样本中观察到的数量(1.75(1.34 - 2.16);p小于0.001)。这是首次证明在炎症状态下核仁组织区数量增加。在25例间皮瘤患者的标本中,相应的核仁组织区数量如下:管状乳头状(n = 10)5.43(4.42 - 6.44);未分化(n = 5)5.00(3.29 - 6.71);肉瘤样(n = 5)7.52(3.96 - 11.08);以及混合组织学类型(n = 5)4.94(3.2 - 6.68)。所有这些值与正常和“反应性”组织的值均有显著差异(p小于0.001)。结论是,AgNOR技术能够高度可靠地区分“反应性”胸膜疾病和间皮瘤,是恶性间皮瘤诊断方面的一项重要进展。